FE Home - Health & Pharma
Ranbaxy arm under US FDA scanner
The US Food and Drug Administration has rapped Ranbaxy’s US-based subsidiary, Ohm Labs Inc, for manufacturing an old ‘unapproved drug’—opium tincture—in a New York manufacturing facility.

High-end medical devices likely to get 30% cheaper

The cost of latest versions of medical devices like ultrasound systems, cardiac diagnostics could fall by 25 to 30% compared to their imported counterparts in the domestic...

Apollo Hospitals to invest 1800 cr for bed strength

Health service provider Apollo Hospitals planned to invest Rs 1,800 crores by 2012 to have bed strength of about 13,500 across 70 operational hospitals in India and overseas.

Drug controller, pharma industry on collision course

The turf war between the pharmaceutical industry and Drug Controller General of India (DCGI) is set to intensify.

Special medical courses for rural India

In an attempt to improve access to medical facilities in rural areas, the health ministry is working in tandem with Medical Council of India to introduce a three-and-a-half-year undergraduate course—Bachelor of Rural Medicine and Surgery.

Dr Reddy's posts $113 mn net loss in Q3

Dr Reddy's Laboratories posted a Rs 5.2 billion consolidated loss ($113 million) in the December quarter.

Ranbaxy acquires Bangalore vaccine firm

Biovel's development pipeline comprises of vaccines and biotherapeutics, the two companies said in a statement.

GVK Biosciences joins hands with ResearchPoint Global

Hyderabad-based contract research firm GVK Biosciences said it has joined hands with US- based worldwide clinical organisation, ResearchPoint Global.

Suven Life Sciences receive patents in Russia, China

These granted patents are exclusive intellectual property of Suven and are achieved through internal discovery research efforts, the Hyderabad-based firm said in a statement.

Dr Reddy's, AstraZeneca may settle patent case out of court

AstraZeneca has filed a lawsuit against Dr Reddy's alleging that the Indian company's generic version of a heartburn drug infringes on its USD 4 billion drug, Nexium.

Novartis to leapfrog Alcon deal

In one stroke, Swiss pharma giant Novartis AG could break into the league of top five players in the Rs 600-crore plus Indian eyecare market from its current position at 13, if its takeover of Alcon goes through seamlessly and eventually results in integration of Alcon India into the Indian arm of Novartis.

Zydus Cadila to conduct trials for H1N1 vaccine

Zydus Cadila said it has received approval from DCGI for conducting clinical trials for the H1N1 vaccine.

Sun gets boost as Taro shareholders reject Board's re-election

In a major boost to Sun Pharma, shareholders of the Israeli drug firm rejected a proposal to re-elect directors.

Ranbaxy exits from Chinese joint venture

Ranbaxy Laboratories said it has sold its entire stake in Chinese joint venture, Ranbaxy Ghuangzhou China, to HNG Chembio Pharmacy Co Ltd for an undisclosed amount.

Fortis to invest Rs 250-cr in FY11

After completing the Wockhardt buy, Fortis plans to invest Rs 250-crore towards expansion.

Sanofi-aventis to acquire Chattem for $1.9 bn

French drug major Sanofi- aventis said it will buy US-based consumer healthcare company Chattem for about USD 1.9 billion.

Fortis to add 600 beds in first half of 2010

Health care provider Fortis will expand and add 600 beds in the first half of 2010.

Ranbaxy to launch Daiichi Sankyo's drug in Africa

The six African countries are Kenya, Mozambique, Nigeria, Tanzania, Uganda, and Zambia.

Aurobindo Pharma gets US FDA nod for anti-allergic syrup

Aurobindo Pharma said it has received the final approval from the US drug regulator for its anti-allergic syrup.

PSI launches online fundraising project on HIV/AIDS

Population Services International's online project offer individuals the opportunity to make contributions to the cause.

Now, a baby treadmill for infants!

Scientists have developed a ‘tiny treadmill’ which will help infants with Down's Syndrome.

Pvt hospital sector may touch Rs 2 lakh cr: Study

The private hospital sector is expected to touch $45 billion in the next three years.

World News

BANKING & FINANCE

POLITICS

Sports

Markets

Companies

Economy

Most Read Article
 
Centre could triple IT spend
Column : Learn right lessons from NTPC’s flop
China is now world's largest exporter
Paypal suspends payment transactions in India
More
Most Emailed Article
 
Retailers turn to co-op movement for better supply chain management
Cement, telecom, capital goods to post higher growth: study
AP mulls unified municipal Act
Ailing sugar co-ops in AP get Rs 270 cr from Centre
More
Express Classifieds
Post and view free classifieds ad
Express Astrology
Know what's in the stars for you